The growth of non-stoichiometric apatites using the constant composition method

The kinetics of the crystal growth of calcium-deficient hydroxyapatites with different stoichiometry (Ca₅-(HPO₄)(PO₄)₃-(OH)₁-) have been investigated at 37°C using the constant composition method. The growth was performed in solutions supersaturated only with respect to Ca₅(PO₄)₃(OH) (HAp) by inoculating with well-characterized seed crystals. The stoichiometry of the grown apatites was consistent with values of 00.185. The deviation from HAp stoichiometry of the growing apatite increased with increasing supersaturation degree (S). The constant composition method also provides relevant information about the solubility behaviour of the growing phase with a definite composition. From the decrease of the normalized growth rate j with decreasing S, an estimate could be made of the composition of the solution for which the growth ceases. The determined solubility product of the grown apatite (4.28×10^-54 M⁹) was higher than the value obtained by the equilibration of the seed material. The results were interpreted on the basis of differences in crystal lattice perfection.This paper was accepted for publication after the 1995 Conference of the European Society of Biomaterials, Oporto, Portugal, 10–13 September.     

Model-based quantification of EELS spectra: Including the fine structure

An extension to model-based electron energy loss spectroscopy (EELS) quantification is reported to improve the possibility of modelling fine structure changes in electron energy loss spectra. An equalisation function is used in the energy loss near edge structure (ELNES) region to model the differences between a single atom differential cross section and the cross section for an atom in a crystal. The equalisation function can be shown to approximate the relative density of unoccupied states for the given excitation edge. On a set of 200 experimental h-BN spectra, this technique leads to statistically acceptable models resulting into unbiased estimates of relative concentrations and making the estimated precisions come very close to the Cramér-Rao lower bound (CRLB). The method greatly expands the useability of model-based EELS quantification to spectra with pronounced fine structure. Another benefit of this model is that one also gets an estimate of the unoccupied density of states for a given excitation edge, without having to do background removal and deconvolution, making the outcome intrinsically more reliable and less noisy.     

Plasmon holographic experiments: theoretical framework

A theoretical framework is described to understand the results of plasmon holography experiments leading to insight in the meaning of the experimental results and pointing out directions for future experiments. The framework is based on the formalism of mutual intensity to describe how coherence is transferred through an optical system. For the inelastic interaction with the object, an expression for the volume plasmon excitations in a free electron gas is used as a model for the behaviour of aluminium. The formalism leads to a clear graphical intuitive tool for understanding the experiments. It becomes evident that the measured coherence is solely related to the angular distribution of the plasmon scattering in the case of bulk plasmons. After describing the framework, the special case of coherence outside a spherical particle is treated and the seemingly controversial idea of a plasmon with a limited coherence length obtained from experiments is clarified.     

Graphite structural transformations during intercalation by HNO3 and exfoliation

Expandable graphite of two types was synthesized by (1) hydrolysis of graphite nitrate of II stage and (2) anodic polarization of graphite in 60% HNO₃. Exfoliated graphite samples were produced by thermal shock of expandable graphite samples in air at 900 °C. A comparative study of microstructural distinctions of both expandable and exfoliated graphite samples was carried out using X-ray diffraction, Raman spectroscopy, electron energy loss spectroscopy and high resolution transmission electron microscopy.     

Life cycle inventory of buildings: A contribution analysis

A companion paper presented the life cycle inventory (LCI) calculation model for buildings as a whole, developed within a global methodology to optimise low energy buildings simultaneously for energy, environmental impact and costs without neglecting the boundary conditions for thermal comfort and indoor air quality. This paper presents the results of a contribution analysis of the life cycle inventory of four typical Belgian residential buildings. The analysis shows the relative small importance of the embodied energy of a building compared to the energy consumption during the usage phase. This conclusion is even more valid when comparing the embodied energy of energy saving measures with the energy savings they realise. In most studied cases, the extra embodied energy for energy saving measures is gained back by the savings in less than 2 years. Only extremely low energy buildings might have a total embodied energy higher than the energy use of the utilisation phase. However, the sum of both remains small and the energy savings realised with these dwellings are large, compared to the energy consumption of average dwellings.     

Syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex)

Primary testicular neoplasms are common in dogs, but metastases to the testes are rare. Three dogs had enlargement of the testes and associated structures. Upon histological examination, the enlargements were due to metastatic adenocarcinomas. Further examination identified the gastrointestinal tract as the primary site of the metastatic neoplasms in all three cases. The testicular metastases reflected widespread metastatic disease. When metastatic adenocarcinoma is found in the testes and associated structures in dogs, the gastrointestinal tract should be examined closely for a primary tumor site.     

Simultaneous microdialysis in brain and blood of the mouse: extracellular and intracellular brain colchicine disposition

A simultaneous brain and blood microdialysis system was developed to study the passage of colchicine through the blood-brain barrier in the mouse. Colchicine was administered as a bolus in the jugular vein (1.5 mg kg-1) and its hippocampal extracellular fluid (ECF) and blood kinetics were determined over a 4 h period using two microdialysis probes, one in the dorsal hippocampus, the other in the inferior vena cava. Colchicine rapidly diffused into the hippocampus (maximum concentration in the first dialysate sample) and brain and blood concentrations declined in parallel, suggesting rapid equilibration between these two compartments. However, only 6. 7% of total blood colchicine, 14% of unbound colchicine was present in the hippocampus suggesting that the P-glycoprotein efflux pump limits colchicine uptake by the brain. We also found, using conventional tissue homogenate analysis in parallel, that the concentration of colchicine in the hippocampal ECF was 10 times less than that in the intracellular space and that the hippocampus colchicine concentration was 2.8 times higher than that of the rest of the brain. This study shows that the simultaneous brain and blood microdialysis can be used to measure the passage of colchicine through the blood-brain barrier and to estimate the brain extra- and intracellular distribution of colchicine.     

Effect of hepatic insufficiency on pharmacokinetics and drug dosing

The liver plays a central role in the pharmacokinetics of many drugs. Liver dysfunction may not only reduce the plasma clearance of a number of drugs eliminated by biotransformation and/or biliary excretion, but it can also affect plasma protein binding which in turn could influence the processes of distribution and elimination. In addition, reduced liver blood flow in patients with chronic liver disease will decrease the systemic clearance of flow limited (high extraction) drugs and portal-systemic shunting may substantially reduce their presystemic elimination (first-pass effect) following oral administration. When selecting a drug and its dosage regimen for a patient with liver disease additional considerations such as altered pharmacodynamics and impaired renal excretion (hepatorenal syndrome) of drugs and metabolites should also be taken into account. Consequently, dosage reduction is necessary for many drugs administered to patients with chronic liver disease such as liver cirrhosis.